drugset / Trial / NCT00691678

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

NCT00691678

Phase 2 Completed 53 enrolled Dawn L. Hershman
NaSingle-groupOpen-labelSupportive care

Summary

Investigators are hoping to learn if glucosamine with chondroitin can help relieve joint pain/stiffness associated with aromatase inhibitors.

Timeline

Start
2008-10
Primary completion
2012-07
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin Unknown 400 mg
Subject Glucosamine Small molecule 500 mg